Navigation Links
Novavax CEO to Present at ACUMENBioFin's 5th Annual Global Healthcare Conference
Date:5/14/2008

ROCKVILLE, Md., May 14 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) Novavax today announced Chief Executive Officer Dr. Rahul Singhvi will present at ACUMENBioFin's 5th Annual Global Healthcare Conference at 5:05 am Eastern time (11:05 am CEST) on May 19 at the Meridien Beach Plaza Hotel in Monaco, the company announced today.

Dr. Singhvi will provide an overview of the company's strategy, research and development progress and its unique manufacturing solution. A link to an audio webcast of his presentation will be available at 5:05 am Eastern time (11:05 am CEST) on Monday, May 19 through the company's website, http://www.novavax.com. An archive of the presentation will be available one hour after the event on the Novavax website for 30 days.

ABOUT NOVAVAX

Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, potent recombinant vaccines utilizing a new, efficient manufacturing solution. Additional information about Novavax is available at http://www.novavax.com and in the Company's various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Novavax Reports First Quarter 2008 Financial Results
2. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
3. Novavax Opens Its First U.S. Vaccine Plant
4. Novavax CEO to Present at the World Vaccine Congress 2008
5. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
6. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
7. Novavax CEO to Present at BIO CEO & Investor Conference
8. Access Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
9. Interleukin Genetics to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
10. ViroPharma to Present at the Seventh Annual JMP Securities Research Conference
11. Nile Therapeutics to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... Jan. 20, 2017 Interpace Diagnostics Group, ... that provides clinically useful molecular diagnostic tests and ... into a securities purchase agreement with three  institutional ... of common stock in a registered direct offering.  ... agreed to sell to the same investors warrants ...
(Date:1/20/2017)... , January 20, 2017 Stock-Callers.com ... conditions have influenced the most recent performances of select ... (NASDAQ: RGLS ), Abeona Therapeutics Inc. (NASDAQ: ... TBPH ), and Sage Therapeutics Inc. (NASDAQ: ... by Grand View Research, global Biotech market size is expected to ...
(Date:1/19/2017)... Research Future has a half cooked research report on Global Liquid ... and expected to reach USD 450 Million by the end of ... ... assessed as a swiftly growing market and expected that the market ... There has been a tremendous growth in the prevalence of cancer ...
(Date:1/19/2017)... ... January 19, 2017 , ... November Research Group, ... biopharmaceutical and medical device manufacturers and regulators, is proud to announce the worldwide ... email client designed to provide product vigilance departments with the flexibility and ease ...
Breaking Biology Technology:
(Date:1/11/2017)... Intoxalock, a leading ignition interlock provider, has ... patent-pending calibration device. With this new technology, Intoxalock is ... data logs and process repairs at service center locations, ... drunk driving through the application of cutting-edge technologies is ... also for the customer who can get back on ...
(Date:1/6/2017)... Calif. , Jan. 6, 2017  Privately-held ... safety studies in healthy volunteers of a novel ... to treat acute pancreatitis. Acute ... typically a mild disorder, but can be very ... failure and sepsis, where extended hospital stays, time ...
(Date:1/6/2017)... Calif. , Jan. 5, 2017  Delta ID ... its iris scanning technology for automotive at CESĀ® 2017. ... GNTX ) to demonstrate the use of iris ... identify and authenticate the driver in a car, and ... during the driving experience. Delta ID and ...
Breaking Biology News(10 mins):